AlzeCure Pharma AB (publ) (ALZCUR.ST)
SEK 1.17
(0.0%)
SEK 1.17
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.60 SEK | 48.72% |
| 2022 | -1.17 SEK | 40.91% |
| 2021 | -1.98 SEK | -8.79% |
| 2020 | -1.82 SEK | -40.0% |
| 2019 | -1.30 SEK | 14.47% |
| 2018 | -1.52 SEK | -166.67% |
| 2017 | -0.57 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.12 SEK | 14.29% |
| 2024 Q1 | -0.14 SEK | 12.5% |
| 2023 Q4 | -0.16 SEK | -33.33% |
| 2023 FY | - SEK | 52.14% |
| 2023 Q3 | -0.12 SEK | 25.0% |
| 2023 Q2 | -0.16 SEK | -6.67% |
| 2023 Q1 | -0.15 SEK | 28.57% |
| 2022 FY | - SEK | 40.91% |
| 2022 Q3 | -0.22 SEK | 48.84% |
| 2022 Q2 | -0.43 SEK | -30.3% |
| 2022 Q1 | -0.33 SEK | 37.74% |
| 2022 Q4 | -0.21 SEK | 4.55% |
| 2021 Q2 | -0.41 SEK | 31.67% |
| 2021 FY | - SEK | -8.79% |
| 2021 Q1 | -0.60 SEK | -33.33% |
| 2021 Q4 | -0.53 SEK | -23.26% |
| 2021 Q3 | -0.43 SEK | -4.88% |
| 2020 Q1 | -0.35 SEK | 12.5% |
| 2020 Q2 | -0.47 SEK | -34.29% |
| 2020 FY | - SEK | -40.0% |
| 2020 Q4 | -0.45 SEK | 18.18% |
| 2020 Q3 | -0.55 SEK | -17.02% |
| 2019 FY | - SEK | 14.47% |
| 2019 Q4 | -0.40 SEK | -17.65% |
| 2019 Q3 | -0.34 SEK | -30.77% |
| 2019 Q2 | -0.26 SEK | 10.34% |
| 2019 Q1 | -0.29 SEK | 12.12% |
| 2018 Q1 | -0.39 SEK | -69.57% |
| 2018 FY | - SEK | -166.67% |
| 2018 Q4 | -0.33 SEK | -43.48% |
| 2018 Q3 | -0.23 SEK | 41.03% |
| 2018 Q2 | -0.39 SEK | 0.0% |
| 2017 Q3 | -0.27 SEK | 0.0% |
| 2017 Q4 | -0.23 SEK | 14.81% |
| 2017 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AcuCort AB | -0.16 SEK | -275.0% |
| BioGaia AB (publ) | 3.62 SEK | 116.575% |
| Enzymatica AB (publ) | -0.28 SEK | -114.286% |
| Enorama Pharma AB (publ) | -1.61 SEK | 62.733% |
| Gabather AB (publ) | -0.65 SEK | 7.692% |
| Klaria Pharma Holding AB (publ.) | -0.36 SEK | -66.667% |
| Moberg Pharma AB (publ) | -1.33 SEK | 54.887% |
| Nanexa AB (publ) | -1.09 SEK | 44.954% |
| Newbury Pharmaceuticals AB (publ) | -0.72 SEK | 16.667% |
| ODI Pharma AB | 0.02 SEK | 2664.103% |
| Orexo AB (publ) | -3.73 SEK | 83.914% |
| Probi AB (publ) | 1.48 SEK | 140.541% |
| Swedencare AB (publ) | 0.37 SEK | 262.162% |
| Swedish Orphan Biovitrum AB (publ) | 7.47 SEK | 108.032% |
| Toleranzia AB | -0.06 SEK | -971.429% |
| Vivesto AB | -0.74 SEK | 18.919% |